Challenges to Value-Enhancing Innovation in Health Care Delivery
Commonalities and Contrasts with Innovation in Drugs and Devices
Purchase Print Copy
|Add to Cart||Paperback50 pages||$18.00||$14.40 20% Web Discount|
Limiting the growth of health care costs while improving population health is perhaps the most important and difficult challenge facing U.S. health policymakers. The role of innovation in advancing these social goals is controversial, with many seeing innovation as a major cause of cost growth and many others viewing innovation as crucial for improving the quality of care and health outcomes. The authors argue that mitigating the tension between improving health and controlling costs requires more-nuanced perspectives on innovation. More specifically, they argue that policymakers should carefully distinguish between innovative activities that are worth their social costs and activities that are not worth their social costs and try to encourage the former and discourage the latter. The paper considers innovation in drugs, devices, and methods of delivering health care, with particular attention to delivery.
Table of Contents
Stages of Innovation and Defining Health Care Innovation
Cross-Cutting Conceptual Perspectives
The "Value Chasm"
Social Value in Drug and Device Innovation
Delivery Innovation and Social Value